CEO Dr. Chris Martin https://adctherapeutics.com/people/martin-chris/ Co-Founded Spirogen Ltd and sold to AstraZeneca for $440 million. Prior to the acquisition, Dr. Martin led numerous Spirogen collaboration transactions, including agreements with Genentech and Seattle Genetics. https://www.genengnews.com/topics/drug-discovery/astrazeneca-acquires-spirogen-for-up-to-440m/